Navigation Links
Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products
Date:6/17/2011

NEW BRUNSWICK, N.J., June 17, 2011 /PRNewswire-USNewswire/ -- Affineti Biologics has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its research in the development of therapeutic and diagnostic products based on new discoveries in oral biology and dental medicine.

According to James M. Golubieski, president of FVCG, the company invested in Affineti because positive results from studies for anti-caries and periodontal therapy look promising in their ability to affect plaque reduction, influencing dental hygiene and systemic medicine.

Affineti founder Dr. Daniel Fine, also a professor and chair, Department of Oral Biology at UMDNJ-New Jersey Dental School, believes the development of products based on his research will prove more effective than others currently available.

His group uses biological principals to create hybrid or fusion proteins that adhere to tissues with potent but non-toxic antimicrobial effects.  He hopes to use these proteins to deliver effective substances locally, avoiding systemic complications. In the short term, Dr. Fine plans to use these proteins in conditions related to the oral cavity and then expand to include mucosal infections in other sites throughout the body.

"We are focused on anti-caries, periodontal disease therapy and dry mouth treatment," Dr. Fine explained. "Additional testing for yeast and bacterial overgrowth will allow us to bring our product for an effective mouthwash for anti-caries, periodontitis and dry mouth to clinical trials shortly."

In addition to the adverse effect of plaque on dental health, current research supports the idea that dental plaque buildup also increases the risk of cardiovascular disease and stroke.

"The link between gum disease and cardiovascular disease is strong enough for us to consider that Dr. Fine's research will impact health on many levels," said Dr. George F. Heinrich, vice chair and CEO of Fo
'/>"/>

SOURCE Foundation Venture Capital Group, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting
2. Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients
3. Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinsons Cure
4. SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide
5. Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation
6. Bill & Melinda Gates Foundation Funds Bold Ideas Including Empty Virus Shells to Improve Polio Immunity, Dirt-Charged Cell Phones, and Fertilizer Pellets that Reduce Health Risks
7. Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
8. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
9. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
10. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
11. FXB Center Partners With The Merck Company Foundation to Reduce Mother-to-Child HIV Transmission Rates in Botswana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 1, 2014 Research and Markets ... "Global Medical Biosensors Market 2014-2018" report to ... Medical biosensors are used to ... detectors. These biosensors monitor health status, disease betterment, ... methods. They are cost-effective and user-friendly devices. Also, ...
(Date:8/1/2014)... 1, 2014  NxStage Medical, Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank , Chief Executive Officer, and ... the 34 th Annual Canaccord Genuity Growth Conference being ... , on Wednesday, August 13 th at 4:30 p.m. ... at http://ir.nxstage.com/ .  About NxStage Medical ...
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3
... Alere Inc. (NYSE: ALR ) ("Alere") announced ... totaling $2.1 billion.  Jefferies Finance LLC, GE Capital Markets, ... as joint lead arrangers for the credit facilities, and ... for the lenders under the credit facilities. ...
... Qmed.com , a UBM Canon publishing group brand ... directory and search engine, announced its supplier profiles are ... websites. This new search functionality allows medical device professionals ... paid listings) in search results when they conduct keyword ...
Cached Medicine Technology:Alere Inc. Announces $2.1 Billion Credit Facilities 2Qmed Profiles Searchable Across All Medical Device Websites 2Qmed Profiles Searchable Across All Medical Device Websites 3
(Date:8/1/2014)... Recently, iFitDress.com, one of the most famous ... of top bridesmaid dresses online. At the moment, ... up to 52% off. According to the company’s senior spokesman, ... , The company’s stock is limited. Those who are ... store as soon as possible. All its products are delicately ...
(Date:8/1/2014)... the University of California, San Diego School of Medicine ... chili peppers produces chronic activation of a receptor ... reaction that ultimately reduces the risk of colorectal tumors. ... 2014 issue of The Journal of Clinical Investigation ... was originally discovered in sensory neurons, where it acts ...
(Date:8/1/2014)... York (PRWEB) August 01, 2014 Parker ... the rights of victims injured by defective medical devices ... would be recalling its Ethicon surgical power morcellator devices ... maker sited concerns involving the spread of cancer associated ... report dated July 31, 2014. , Johnson & ...
(Date:8/1/2014)... 2014 (HealthDay News) -- The U.S. Food and Drug ... drug, Jardiance, to help fight type 2 diabetes. ... to existing treatment regimens to control blood sugar levels ... director of the Office of Drug Evaluation II in ... in an agency statement. The FDA also recommended ...
(Date:8/1/2014)... New York, New York (PRWEB) August 01, 2014 ... ( http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly ... use of power morcellators in gynecological surgeries, Bernstein Liebhard ... decision to withdraw a number of power morcellators marketed ... to a report from The New York Times, some ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4
... MDTH ) announced today that James E. Harris has ... become the Chief,Financial Officer for Charlotte, N.C. based Coca-Cola ... years, affiliation having,served on its Board of Directors and ... until near the end of January 2008, has been,with ...
... Allscripts, the leading,provider of clinical software, connectivity ... healthcare, today announced that the company,s,TouchWorks(TM) Electronic ... 1 product,in its market segment by the ... http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ), TouchWorks earned the "Best ...
... Agency Adds 23 Clients in US, Europe and ... America,s largest and,fastest growing pay-for-placement public relations agency, ... businesses from South America to Asia.,The two-year old ... in a range of industries including financial services,healthcare, ...
... Officials, Legal Experts to Discuss Latest Criminal,Cases, Decrees and ... WASHINGTON, Dec. 20 In the last year,mainstream ... than $1.9,billion in fines, civil settlements and penalties. Top ... they did not,participate in or know about the crimes., ...
... ... heart disease patients, DETROIT, Dec. 20 Studies ... depression than those without heart,disease. The link between these two diseases ... heart patients is under-recognized and,even when diagnosed, under-treated., That,s why ...
... New Site Leadership Team at Cambridge Facility -, ... of its role as the global biologics unit ... D. Skibo has joined the company,as senior vice ... of the company, has been promoted to vice ...
Cached Medicine News:Health News:James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:PayPerClip Grows 370% in 2007 2Health News:Food and Drug Law Institute Sponsors Major Enforcement Conference 2Health News:Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression 2Health News:MedImmune Expands Scientific and Engineering Leadership 2Health News:MedImmune Expands Scientific and Engineering Leadership 3Health News:MedImmune Expands Scientific and Engineering Leadership 4Health News:MedImmune Expands Scientific and Engineering Leadership 5
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... a complete offering of cardiology catheters. Available ... catheters are designed with excellent torque, new ... better push-ability, and large inner lumens for ... 6 and 7 French sizes with pressure ...
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Medicine Products: